NYSE American - Delayed Quote USD

Perspective Therapeutics, Inc. (CATX)

3.3200
+0.2000
+(6.41%)
At close: June 6 at 4:00:00 PM EDT
3.3400
+0.02
+(0.60%)
After hours: June 6 at 7:50:44 PM EDT

Insider Purchases Last 6 Months

SharesTransactions
Purchases 0 0
Sales -- 0
Net Shares Purchased (Sold) 0 0
Total Insider Shares Held 13.98M --
% Net Shares Purchased (Sold) -- --

Net Institutional Purchases Prior Quarter to Latest Quarter

Shares
Net Shares Purchased (Sold) --
% Change in Institutional Shares Held --

Insider Transactions Reported - Last Two Years

InsiderTransactionTypeValueDate
WOODS LORI A. Director Purchase at price 2.13 per share. Indirect 49,999 Mar 31, 2025
WILLIAMSON ROBERT F III Director Purchase at price 2.14 - 2.27 per share. Direct 132,151 Mar 31, 2025
SPOOR JOHAN M Chief Executive Officer Purchase at price 2.21 - 2.24 per share. Indirect 59,673 Mar 28, 2025
GRAHAM JUAN Chief Financial Officer Purchase at price 2.25 per share. Direct 74,946 Mar 28, 2025
HENSON HEIDI Director Purchase at price 3.85 per share. Indirect 100,004 Dec 4, 2024
SPOOR JOHAN M Chief Executive Officer Purchase at price 3.77 per share. Direct 30,132 Dec 4, 2024
HUNT JONATHAN ROBERT Chief Financial Officer Purchase at price 3.55 - 3.94 per share. Direct 48,974 Nov 25, 2024
WILLIAMSON ROBERT F III Director Purchase at price 3.62 - 3.67 per share. Direct 22,814 Nov 25, 2024
SPOOR JOHAN M Chief Executive Officer Purchase at price 3.78 - 3.80 per share. Indirect 100,468 Nov 25, 2024
HUNT JONATHAN ROBERT Chief Financial Officer Purchase at price 1.03 per share. Direct 1,861 Jun 17, 2024
WOODS LORI A. Director Purchase at price 1.07 per share. Indirect 4,908 Jun 14, 2024
SPOOR JOHAN M Chief Executive Officer Purchase at price 1.17 per share. Direct 117,430 Jun 13, 2024
WOODS LORI A. Director Purchase at price 1.46 per share. Indirect 49,992 Jun 3, 2024
HUNT JONATHAN ROBERT Chief Financial Officer Purchase at price 1.40 per share. Direct 35,007 May 31, 2024
WILLIAMSON ROBERT F III Director Purchase at price 1.38 per share. Direct 75,900 May 31, 2024
WILLIAMSON ROBERT F III Director Purchase at price 1.32 - 1.34 per share. Direct 40,014 May 29, 2024
AUSTIN MARK JOHN Chief Financial Officer Conversion of Exercise of derivative security at price 0.36 per share. Direct 10,800 Apr 23, 2024
LANTHEUS ALPHA THERAPY, LLC Beneficial Owner of more than 10% of a Class of Security Purchase at price 0.95 per share. Indirect 57,409,487 Mar 6, 2024
WILLIAMSON ROBERT F III Director Purchase at price 0.70 - 0.72 per share. Direct 90,710 Jan 30, 2024
WILLIAMSON ROBERT F III Director Purchase at price 0.54 - 0.64 per share. Direct 78,474 Jan 29, 2024
WILLIAMSON ROBERT F III Director Purchase at price 0.49 per share. Direct 25,478 Jan 25, 2024
PUHLMANN MARKUS Officer Purchase at price 0.50 per share. Direct 139,888 Jan 24, 2024
WILLIAMSON ROBERT F III Director Purchase at price 0.33 per share. Indirect 1,203 Dec 21, 2023
WILLIAMSON ROBERT F III Director Purchase at price 0.26 - 0.32 per share. Direct 6,978 Dec 19, 2023
PUHLMANN MARKUS Officer Purchase at price 0.26 - 0.34 per share. Direct 188,737 Dec 19, 2023
HUNT JONATHAN ROBERT Chief Financial Officer Purchase at price 0.26 per share. Direct 32,338 Dec 18, 2023
WOODS LORI A. Director Purchase at price 0.27 per share. Indirect 49,989 Dec 15, 2023

Related Tickers